Hangzhou Zhiyan Dongli Jishu Management Consulting is engaged in power technology consulting, investment management, etc.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 1, 2020
CANbridge Pharmaceuticals
|
Series E | $43M | Biotechnology | — |
Jul 31, 2017
Metalab
|
Series B | ¥20M | Business Development | Yes |
Hangzhou Zhiyan Dongli Jishu Management Consulting has had 1 exits. Hangzhou Zhiyan Dongli Jishu Management Consulting most notable exits include CANbridge Pharmaceuticals
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 10, 2021 | CANbridge Pharmaceuticals | IPO | Biotechnology | Detail |